The US FDA has published recommendations for maintaining data integrity in clinical trials during the SARS-COVID 19 emergency response period.
Read the recommendations here.
The US FDA has published recommendations for maintaining data integrity in clinical trials during the SARS-COVID 19 emergency response period.
Read the recommendations here.
Be the first to know all ACTA events and featured news through our Newsletter.
You don’t need to be a member to subscribe!